Diabetes and acute bacterial skin and skin structure infections
نویسندگان
چکیده
منابع مشابه
Early endpoints for acute bacterial skin and skin structure infections.
In this issue of the journal, Friedland et al. (4) present a retrospective analysis of the two CANVAS trials (3), employing the newer endpoints from the U.S. Food and Drug Administration (FDA) (7). First, they are to be congratulated for having the foresight to include sufficient measurements in their trial to allow the reanalysis even prior to the issuance of the new guidelines. The analysis e...
متن کاملCeftaroline fosamil and treatment of acute bacterial skin and skin structure infections: CAPTURE study experience
The Clinical Assessment Program and TEFLARO Utilization Registry (CAPTURE) is a multicentre retrospective cohort study in the USA describing treatment of acute bacterial skin and skin structure infection (ABSSSI) with ceftaroline fosamil (CPT-F). Charts for review were chosen by random selection. Among 647 evaluable patients, 52% were obese, 46% had diabetes mellitus (DM), and 19% had periphera...
متن کاملSkin Infections and Travelers
Knowing the type of infections in different geographical regions may help to prevent the distribution of diseases. Vaccines, repellents, mosquito nets and clothes are recommended for preventing the increase of infectious diseases. There are different types of climate and geographical items around the world which determine the kind of skin infections. Travelers' skin diseases are recognized as s...
متن کاملDalbavancin for the treatment of acute bacterial skin and skin structure infections.
Dalbavancin is a novel parenteral lipoglycopeptide antibiotic approved for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in adults. Dalbavancin is highly active against common Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). Dalbavancin has a prolonged half-life that allows for once weekly dosing. Phase III trials have demons...
متن کاملPAGE TWO — IDSA Comments on Acute Bacterial Skin and Skin Structure Infections Guidance
The enclosed comments on the above-referenced Food and Drug Administration (FDA) Draft Guidance concerning Acute Bacterial Skin and Skin Structure Infections (ABSSSI) are submitted by the Infectious Diseases Society of America (IDSA). IDSA represents more than 9300 infectious diseases physicians and scientists devoted to patient care, prevention, public health, education, and research in the ar...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Diabetes Research and Clinical Practice
سال: 2021
ISSN: 0168-8227
DOI: 10.1016/j.diabres.2021.108732